Document is current
Any future updates will be listed below
-
Authors
Sakamoto, Mandy https://orcid.org/0000-0002-1570-5076
Patil, Tejas https://orcid.org/0000-0003-4389-1010
-
Funding
Funding for this research was provided by:
Cancer League of Colorado (AWD#222595-TP)
LUNGevity Foundation (2022-23)
- License Information
-
More Information
Article History
Received: 8 February 2023
Accepted: 28 April 2023
First Online: 8 June 2023
Competing interests
: M.S. has no declared conflicts of interest. T.P. has the following conflicts of interest: He has received honoraria for an advisory role (advisory boards or consultations) from the following: Astrazeneca, Biocept, Bristol-Myers Squibb, Bicara, Caris, Guardant Health, EMD Soreno, Janssen, Mirati Therapeutics, Natera, Pfizer, Sanofi, Regeneron, Roche/Genentech, Takeda. He is on the Data Safety Monitoring Board (DSMB) for Elevation Oncology. He has received research funding for investigator-initiated trials from EMD Soreno and Janssen.
